High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$63.1M
$63,132,521
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $124,282 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $452,918 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $1,590,979Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $1,284,019Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $592,535 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $508,430 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $766,198 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $954,762 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $173,419 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $152,280 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2026-03-04 | $104,729 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $245,231 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $647,773 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $2,330,151Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $538,741 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $624,619 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $774,289 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $814,802 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $357,838 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $121,438 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-03-02
$200,700
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-03-02 | $200,700 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-27 | $655,343 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -11.1%
2026-02-27
$2,597,481Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2026-02-27 | $2,597,481Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-26 | $1,404,760Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-26 | $728,919 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-25 | $192,500 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $16,309 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
Other
|
2026-02-24 | $93,222 | M | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $149,594 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $457,728 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $942,878 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -28.1%
2026-02-24
$2,391,885Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -28.1%
|
2026-02-24 | $2,391,885Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -50.6%
2026-02-24
$3,116,310Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -50.6%
|
2026-02-24 | $3,116,310Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -58.6%
2026-02-24
$1,788,079Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -58.6%
|
2026-02-24 | $1,788,079Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -84.2%
2026-02-24
$1,065,924Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -84.2%
|
2026-02-24 | $1,065,924Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -49.8%
|
2026-02-24 | $99,836 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $101,118 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $238,136 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $425,919 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $1,156,879Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $505,597 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $449,747 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $250,636 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $666,627 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
Discretionary Sell
|
2026-02-19 | $2,114,103Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROSSI DINO A
• Director
Discretionary SellΔOwn -12.1%
2026-02-19
$2,839,591Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
Discretionary SellΔOwn -12.1%
|
2026-02-19 | $2,839,591Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
Other
|
2026-02-19 | $166,570 | M | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-02-09
$254,001
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-02-09 | $254,001 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-02-09
$151,601
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-02-09 | $151,601 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-02-09
$110,272
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-02-09 | $110,272 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-02-09
$26,676
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-02-09 | $26,676 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 Sell
2026-02-09
$541,116
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 Sell
|
2026-02-09 | $541,116 | S | Form 4 |
|
KRYS
M
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
Other
2026-02-09
$794,375
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
Other
|
2026-02-09 | $794,375 | M | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 SellΔOwn -19.1%
2026-02-09
$1,548,477Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 SellΔOwn -19.1%
|
2026-02-09 | $1,548,477Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
ROMANO KATHRYN
• Officer • Chief Accounting Officer
10b5-1 SellΔOwn -11.7%
2026-02-09
$769,562
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Officer • Chief Accounting Officer
10b5-1 SellΔOwn -11.7%
|
2026-02-09 | $769,562 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $2,329,772Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $578,395 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $1,249,917Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $563,638 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $347,272 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $74,126 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $347,272 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $74,126 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $204,851 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $44,475 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $2,320,471Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $579,301 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $1,190,423Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $786,245 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $303,754 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $149,975 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $1,249,803Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $578,395 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $2,329,772Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $155,539 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $129,296 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
President
10b5-1 Sell
|
2025-12-04 | $563,638 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $44,475 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $2,320,471Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $579,301 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $1,190,423Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $786,245 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $303,754 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $129,296 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $149,975 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $204,851 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $155,539 | S | Form 4 |